Sponsor: BioNTech Pharmaceuticals
Sponsor Study ID: BNT-122-01
Study Title: A multi-site, open-label, Phase II, randomized, controlled Trial to compare the Efficacy of RO7198457 Versus Watchful Waiting in resected, Stage II (high risk) and Stage III Colorectal Cancer patients who are ctDNA positive following resection
CTO #: 103669
NCT Number: NCT04486378
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Colon
Study Objectives: To demonstrate superiority of RO7198457 compared to watchful waiting in terms of DFS in chemotherapy pre-treated patients.